POPULAR SECTIONS

TREATMENT REGIMENS DRUG INFO MEDICAL CALCULATORS PUBLISHERS ALLIANCE VIDEOS CME

Latest News

For HER2-Positive Metastatic Breast Cancer, Pertuzumab Significantly Improves Survival

For HER2-Positive Metastatic Breast Cancer, Pertuzumab Significantly Improves Survival

HER2-positive breast cancer treated with pertuzumab, trastuzumab, and chemotherapy, lived about 16 months longer.

For HER2-Positive Breast Cancer, Trastuzumab More Effective Than Lapatinib

For HER2-Positive Breast Cancer, Trastuzumab More Effective Than Lapatinib

Trastuzumab in combination with standard chemotherapy for breast cancer leads to better outcomes.

For Cervical Cancer, Cediranib Plus Chemotherapy Prolongs Progression-Free Survival

For Cervical Cancer, Cediranib Plus Chemotherapy Prolongs Progression-Free Survival

Cediranib with carboplatin and paclitaxel improved tumor shrinkage in patients with recurrent cervical cancer.

For Pancreatic Cancer, Possible Biomarker Identified

For Pancreatic Cancer, Possible Biomarker Identified

A biomarker in the blood that may indicate early development of pancreatic cancer

Higher Lipoprotein Cholesterol May Protect Against Cancer

Higher Lipoprotein Cholesterol May Protect Against Cancer

Findings based on large retrospective study of patients with type 2 diabetes.

Researchers Use Bacillus Anthracis to Deliver Antibodies to Cancer Cells

Researchers Use Bacillus Anthracis to Deliver Antibodies to Cancer Cells

Researchers have successfully rendered Bacillus anthracis bacteria nontoxic to deliver antibody mimics to cancer cells.

Pleiotrophin Key to Accelerating Blood System Recovery

Pleiotrophin Key to Accelerating Blood System Recovery

A particular protein in the bone marrow prompts stem cells to repair the human blood system after chemotherapy and radiation

In Ovarian Cancer, Gelsolin Causes Cisplatin Resistance

In Ovarian Cancer, Gelsolin Causes Cisplatin Resistance

Increased levels of gelsolin associated with aggressive forms of ovarian cancer.

Leo1 Gene Increases Risk for Developing Acute Myelogenous Leukemia (AML)

Leo1 Gene Increases Risk for Developing Acute Myelogenous Leukemia (AML)

A gene called Leo1 leads to an increased risk for developing acute myelogenous leukemia (AML).

NSAIDs Tied to Venous Thromboembolism (VTE) Risk

NSAIDs Tied to Venous Thromboembolism (VTE) Risk

NSAIDs should be prescribed with caution, especially in patients already at a higher risk of VTE.

FDG-PET Technology May Misdiagnose Lung Infections for Cancer

FDG-PET Technology May Misdiagnose Lung Infections for Cancer

Researchers found that FDG-PET technology was associated with more false positive results.

For Non-Small Cell Lung Cancer (NSCLC) Refractory to Crizotinib, Alectinib May Be Effective

For Non-Small Cell Lung Cancer (NSCLC) Refractory to Crizotinib, Alectinib May Be Effective

Alectinib may be effective treatment for patients with non-small cell lung cancer (NSCLC), refractory to crizotinib.

For Chronic Lymphocytic Lymphoma (CLL) and Mantle Cell Lymphoma (MCL), Ibrutinib Plus ABT-199 May Be Effective

For Chronic Lymphocytic Lymphoma (CLL) and Mantle Cell Lymphoma (MCL), Ibrutinib Plus ABT-199 May Be Effective

Ibrutinib in combination with ABT-199 may be effective for mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL).

For Highly Aggressive Acute Myeloid Leukemia (AML), CX-5461 May Be Effective

For Highly Aggressive Acute Myeloid Leukemia (AML), CX-5461 May Be Effective

CX-5461, which that inhibits RNA polymerase 1, may improve survival for patients with highly aggressive acute myeloid leukemia.

Tumor Vulnerability in Acute Lymphoblastic Leukemia (ALL) Varies with Clonal Evolution

Tumor Vulnerability in Acute Lymphoblastic Leukemia (ALL) Varies with Clonal Evolution

Description of new approach to combat drug resistance in hematologic malignancies.

More News

Health Care Expenditure Slowed in US

Health sector prices explain much of difference between U.S. and other high-spending countries.

States Concerned About Higher-Than-Expected Medicaid Enrollment

Millions signing up for Medicaid to comply with federal health care law.

EHR Use More Than Doubles

Almost 80% of doctors in the United States have switched from paper to electronic health records.

Many Docs Order Unnecessary Medical Tests

Most physicians believe that doctors order too many medical tests, yet half admit to doing so themselves in response to a patient who insists, a new survey shows.

Reducing Six Risk Factors May Prevent 37 Million Deaths

Several modifiable risk factors can cut chronic disease deaths over the next 15 years.

Majority of Women Lack Accurate Knowledge of Their Own Breast Cancer Risk

Caucasian women overestimate their risk of breast cancer while African American and Hispanic women underestimate their risk, according to research presented at BCS 2013.

Survey Identifies Modifiable Barriers to Mammography Screening Among Rural US Women

A survey presented at BCS 2013 has found a number of factors that cause rural US women to avoid breast cancer screening.

Perioperative MRI of Uncertain Benefit for Women with DCIS

The benefit of perioperative MRI for women with ductal carcinoma in situ (DCIS) is "uncertain," found a study presented during BCS 2013.

Dr. Edith Perez's Recommended Abstracts at BCS 2013

ChemotherapyAdvisor.com Editorial Board member Dr. Edith Perez of the Mayo Clinic, Jacksonville, FL, recommends high impact abstracts at the Breast Cancer Symposium 2013.

Radiotherapy for DCIS Is Not Associated With Increased Cardiovascular Disease

Women who underwent radiation for ductal carcinoma in situ do not face an increased risk of cardiovascular disease, found a study presented at BCS 2013.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs